This proposal represents the first competing renewal of our Training Grant. During the last 4 years, our Training Grant has provided M.D. Trainees the opportunity to develop a strong foundation in lung science. Of our cohort of 7 trainees completing the training program, have secured academic positions and 3 already have successfully competed for NIH funds. There are three major goals of our Training Program: (1) to provide 3 years of rigorous scientific training for physician-scientists enabling them to serve as independent investigators examining scientific questions directly related to human lung disease; (2) to provide up to 3 years of postdoctoral training to Ph.D. scientists choosing to focus their studies on lung biology; (3) to train graduate students from two established Ph.D. granting programs (""""""""MIMP"""""""" our acronym for the combined graduated program in Microbiology, Immunobiology and Molecular Pathobiology; and """"""""BMBB"""""""" the combined graduate program in Microbiology, Immunobiology and Biophysics), and guide them toward a scientific career in lung biology. Our program features close contact between the trainee and Training Faculty from 4 collegiate units in our Academic Health Center, and the College of Engineering (Institute of Technology). We continue to provide training in 3 major curricular areas: (1) Cell and Molecular Biology; (this area includes the programs in MIMP and BMBB); (2) Bioengineering and Integrative Physiology; (3) Clinical and Epidemiological studies leading to a Masters in Public Health. Comprehensive resources and stable research funding in each area provide an outstanding training environment.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
5T32HL007741-08
Application #
6343412
Study Section
Special Emphasis Panel (ZHL1-CSR-K (F1))
Program Officer
Colombini-Hatch, Sandra
Project Start
1994-07-15
Project End
2004-06-30
Budget Start
2001-07-01
Budget End
2002-06-30
Support Year
8
Fiscal Year
2001
Total Cost
$562,448
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
168559177
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Truong, Thu H; Hu, Hsiangyu; Temiz, Nuri A et al. (2018) Cancer Stem Cell Phenotypes in ER+ Breast Cancer Models Are Promoted by PELP1/AIB1 Complexes. Mol Cancer Res 16:707-719
Simones, Ann A; Beisang, Daniel J; Panoskaltsis-Mortari, Angela et al. (2018) Mesenchymal stem cells in the pathogenesis and treatment of bronchopulmonary dysplasia: a clinical review. Pediatr Res 83:308-317
Herrera, Jeremy; Beisang, Daniel J; Peterson, Mark et al. (2018) Dicer1 Deficiency in the Idiopathic Pulmonary Fibrosis Fibroblastic Focus Promotes Fibrosis by Suppressing MicroRNA Biogenesis. Am J Respir Crit Care Med 198:486-496
Sjaastad, Louisa E; Fay, Elizabeth J; Fiege, Jessica K et al. (2018) Distinct antiviral signatures revealed by the magnitude and round of influenza virus replication in vivo. Proc Natl Acad Sci U S A 115:9610-9615
Chesner, Lisa N; Campbell, Colin (2018) A quantitative PCR-based assay reveals that nucleotide excision repair plays a predominant role in the removal of DNA-protein crosslinks from plasmids transfected into mammalian cells. DNA Repair (Amst) 62:18-27
Yang, Libang; Herrera, Jeremy; Gilbertsen, Adam et al. (2018) IL-8 mediates idiopathic pulmonary fibrosis mesenchymal progenitor cell fibrogenicity. Am J Physiol Lung Cell Mol Physiol 314:L127-L136
Chesner, Lisa N; Campbell, Colin (2018) A Simple, Rapid, and Quantitative Assay to Measure Repair of DNA-protein Crosslinks on Plasmids Transfected into Mammalian Cells. J Vis Exp :
Flanders, Scott C; Kim, Janet; Wilson, Samuel et al. (2018) Validating the total illness burden index for prostate cancer (TIBI-CaP) in men with castration-resistant prostate cancer: data from TRUMPET. Future Oncol 14:527-536
Herrera, Jeremy; Henke, Craig A; Bitterman, Peter B (2018) Extracellular matrix as a driver of progressive fibrosis. J Clin Invest 128:45-53
Leehy, Katherine A; Truong, Thu H; Mauro, Laura J et al. (2018) Progesterone receptors (PR) mediate STAT actions: PR and prolactin receptor signaling crosstalk in breast cancer models. J Steroid Biochem Mol Biol 176:88-93

Showing the most recent 10 out of 114 publications